Artelo Biosciences (NASDAQ:ARTL) Earns Buy Rating from Analysts at Maxim Group
Maxim Group assumed coverage on shares of Artelo Biosciences (NASDAQ:ARTL) in a research note published on Tuesday morning, The Fly reports. The brokerage issued a buy rating and a $8.00 target price on the stock.
Shares of NASDAQ:ARTL opened at $3.90 on Tuesday. Artelo Biosciences has a 12-month low of $1.62 and a 12-month high of $10.50.
Artelo Biosciences Company Profile
Further Reading: What is meant by a buy rating?
Receive News & Ratings for Artelo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Artelo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.